Psoriasis is associated with decreased plasma adiponectin levels independently of cardiometabolic risk factors

被引:44
|
作者
Li, R. C. [1 ,2 ]
Krishnamoorthy, P. [1 ]
DerOhannessian, S. [1 ]
Doveikis, J. [1 ]
Wilcox, M. [1 ]
Thomas, P. [3 ]
Rader, D. J. [1 ,2 ]
Reilly, M. P. [1 ,2 ]
Van Voorhees, A. [4 ]
Gelfand, J. M. [2 ,4 ]
Mehta, N. N. [5 ]
机构
[1] Univ Penn, Cardiovasc Inst, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Ctr Clin Epidemiol & Biostat, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Hosp Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[4] Hosp Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA
[5] NHLBI, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
ADIPOSE-TISSUE; INSULIN-RESISTANCE; METABOLIC SYNDROME; INFLAMMATION; ADIPOKINES; EXPRESSION; IMMUNITY; OBESITY;
D O I
10.1111/ced.12250
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BackgroundPsoriasis is an inflammatory skin disease that may be associated with an adverse cardiometabolic profile including modulated plasma adiponectin and leptin levels. Whether these levels are independent of cardiometabolic risk factors, which are also prevalent in psoriasis, is not known. MethodsA consecutive sample of 122 participants with varying degrees of psoriasis severity, and a random sample of 134 participants without psoriasis, were recruited for this case-control study. Cardiometabolic risk factors including traditional cardiovascular risk factors, waist circumference, insulin resistance, and total plasma adiponectin and leptin were measured. Total plasma adiponectin and leptin levels were compared in unadjusted and adjusted analyses by psoriasis status. ResultsParticipants with psoriasis had mostly mild disease and were mainly on topical therapies, but still had a more adverse cardiometabolic profile compared with those without psoriasis. Furthermore, plasma adiponectin levels were significantly lower in participants with psoriasis than those without {7.13g/mL [interquartile range (IQR) 4.9-11.3) vs. 14.5g/mL (IQR 8.4-24.1); P<0.001]}. Plasma leptin (ng/mL) levels were higher in the psoriasis group but this did not reach statistical significance [11.3 (IQR 6.4-21.8) vs. 9.8 (IQR 4.9-20.5); P=0.07]. In multivariable modelling, plasma adiponectin levels were still negatively associated with psoriasis status after adjusting for waist size (% difference=-41.2%, P<0.001), insulin resistance (% difference=-39.5%, P<0.001), and both waist size and insulin resistance (% difference=-38.5%, P<0.001). ConclusionsPlasma levels of adiponectin were lower in psoriasis, and this relationship persisted after adjusting for cardiometabolic risk factors known to decrease adiponectin levels. These findings suggest that inflammation present in psoriasis may be associated with adipose tissue dysfunction; however, direct studies of adipose tissue are needed to confirm this.
引用
收藏
页码:19 / 24
页数:6
相关论文
共 50 条
  • [21] Enterotype May Drive the Dietary-Associated Cardiometabolic Risk Factors
    de Moraes, Ana C. F.
    Fernandes, Gabriel R.
    da Silva, Isis T.
    Almeida-Pititto, Bianca
    Gomes, Everton P.
    Pereira, Alexandre da Costa
    Ferreira, Sandra R. G.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2017, 7
  • [22] The presence of abdominal obesity is associated with changes in vascular function independently of other cardiovascular risk factors
    Rueda-Clausen, Christian F.
    Lahera, Vicente
    Calderon, Jaime
    Cristina Bolivar, Isabel
    Castillo, Victor R.
    Gutierrez, Melquisedec
    Carreno, Marisol
    del Pilar Oubina, Maria
    Cachofeiro, Victoria
    Lopez-Jaramillo, Patricio
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 139 (01) : 32 - 41
  • [23] Factors influencing cardiometabolic risk profile in patients with psoriasis
    Curco, Neus
    Barriendos, Nuria
    Jose Barahona, Maria
    Arteaga, Carmen
    Garcia, Mercedes
    Yordanov, Stanislav
    De La Barrera, Olimpia
    Prat, Carolina
    Vives, Pere
    Gimenez, Nuria
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2018, 59 (02) : E93 - E98
  • [24] Higher adiponectin concentrations are associated with reduced metabolic syndrome risk independently of weight status in Brazilian adolescents
    Sparrenberger, Karen
    Sbaraini, Mariana
    Cureau, Felipe Vogt
    Telo, Gabriela Heiden
    Bahia, Luciana
    Schaan, Beatriz D.
    DIABETOLOGY & METABOLIC SYNDROME, 2019, 11 (1)
  • [25] Accuracy of plasma interleukin-18 and adiponectin concentrations in predicting metabolic syndrome and cardiometabolic disease risk in middle-age Brazilian men
    de Oliveira, Alessandro
    Hermsdorff, Helen Hermana
    Cocate, Paula G.
    Santos, Eliziaria C.
    Bressan, Josefina
    Natali, Antonio Jose
    APPLIED PHYSIOLOGY NUTRITION AND METABOLISM, 2015, 40 (10) : 1048 - 1055
  • [26] Plasma Adiponectin Levels are Associated with Insulin Sensitivity in Stroke Survivors
    Ryan, Alice S.
    Macko, Richard E.
    Peters, Matthew N.
    Ivey, Frederick M.
    Prior, Steven J.
    Joseph, Lyndon J.
    Hafer-Macko, Charlene E.
    JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2009, 18 (03) : 214 - 220
  • [27] The Association of Serum Circulating Neuropeptide Q and Chemerin Levels with Cardiometabolic Risk Factors among Patients with Metabolic Syndrome
    Pelczynska, Marta
    Mikulska, Aniceta Ada
    Czyzewska, Krystyna
    Bogdanski, Pawel
    Grzelak, Teresa
    BIOMOLECULES, 2021, 11 (12)
  • [28] Vitamin D levels and cardiometabolic risk factors in Portuguese adolescents
    Cabral, Maria
    Araujo, Joana
    Teixeira, Joana
    Barros, Henrique
    Martins, Sandra
    Guimaraes, Joao Tiago
    Lopes, Carla
    Ramos, Elisabete
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2016, 220 : 501 - 507
  • [29] LEVELS OF VITAMIN D AND CARDIOMETABOLIC RISK FACTORS IN OBESITY ADOLESCENTS
    Shulhay, A. M. A.
    Pavlyshyn, H. A.
    WORLD OF MEDICINE AND BIOLOGY, 2019, 68 (02): : 148 - +
  • [30] Associations of single nucleotide polymorphisms in the adiponectin gene with adiponectin levels and cardio-metabolic risk factors in patients with cancer
    Al Khaldi, Rasha Mazen
    Al Mulla, Fahd
    Al Awadhi, Shafika
    Kapila, Kusum
    Mojiminiyi, Olusegun A.
    DISEASE MARKERS, 2011, 30 (04) : 197 - 212